95% CI | |||||
---|---|---|---|---|---|
Variable | Comparison | Adjusted OR | Lower | Upper | p Value |
PPI | |||||
Age category | 10-year increase in age | 1.137 | 0.971 | 1.332 | 0.1098 |
Serum albumin | <2.5 vs ≥2.5 g/dL | 0.992 | 0.604 | 1.629 | 0.9738 |
Serum creatinine | ≥1.5 vs <1.5 mg/dL | 1.657 | 0.948 | 2.896 | 0.0761 |
WCC | ≥15×109 vs <15×109/L | 0.998 | 0.560 | 1.778 | 0.9951 |
Treatment | Fidaxomicin vs vancomycin | 0.488 | 0.306 | 0.778 | 0.0026 |
PPI use | Yes vs no | 1.539 | 0.953 | 2.484 | 0.0781 |
H2RA | |||||
Age category | 10-year increase in age | 1.138 | 0.973 | 1.332 | 0.1064 |
Serum albumin | <2.5 vs ≥2.5 g/dL | 1.021 | 0.621 | 1.677 | 0.9351 |
Serum creatinine | ≥1.5 vs <1.5 mg/dL | 1.776 | 1.018 | 3.101 | 0.0432 |
WCC | ≥15×109 vs <15×109/L | 0.954 | 0.536 | 1.697 | 0.8719 |
Treatment | Fidaxomicin vs vancomycin | 0.506 | 0.318 | 0.804 | 0.0039 |
H2RA use | Yes vs no | 0.493 | 0.202 | 1.202 | 0.1199 |
PPI and/or H2RA | |||||
Age category | 10-year increase in age | 1.141 | 0.975 | 1.335 | 0.1007 |
Serum albumin | <2.5 vs ≥2.5 g/dL | 0.995 | 0.606 | 1.636 | 0.9856 |
Serum creatinine | ≥1.5 vs <1.5 mg/dL | 1.688 | 0.967 | 2.948 | 0.0654 |
WCC | ≥15×109 vs <15×109/L | 1.004 | 0.563 | 1.791 | 0.9879 |
Treatment | Fidaxomicin vs vancomycin | 0.498 | 0.313 | 0.793 | 0.0033 |
PPI/H2RA use | Yes vs no | 1.353 | 0.828 | 2.212 | 0.2275 |
H2RA, histamine-2 receptor antagonist; mITT, modified intent to treat; PPI, proton pump inhibitor; WCC, white cell count.